Tesla's High-Stakes European and Industrial Pivot

Tesla gains first EU commercial approval for Full Self-Driving, while its Fremont factory prepares to stop Model S/X production and mass-produce Optimus humanoid robots.

The Tesla investment thesis is undergoing a profound transformation, with two major developments this month highlighting the company's dual-track future. While securing Europe's first commercial approval for its Full Self-Driving system, the automaker is simultaneously preparing its Fremont factory for a radical shift from legacy car production to humanoid robotics.

On April 10, the Dutch vehicle authority RDW granted the first European type approval for Full Self-Driving Supervised. This landmark decision allows Tesla to commercially offer its hands-free driver-assistance system on public EU roads, starting with a rollout in the Netherlands just one day later. The path to approval was arduous, involving 18 months of testing, 1.6 million kilometers driven on European roads, 13,000 customer test drives, and compliance with over 400 documented requirements. The service is priced at 99 euros per month or 7,500 euros as a one-time purchase.

This regulatory breakthrough carries significant weight for CEO Elon Musk personally. His 2025 compensation package includes a clause requiring ten million active FSD subscriptions before his stock options expire. During the Q4 2025 earnings call, Tesla reported just one million subscribers. Gaining access to Europe's subscription market directly accelerates progress toward that critical target. Strategically, Tesla anticipates that EU-wide recognition of the Dutch approval could come by summer 2026, potentially opening the German and French markets without another 18-month testing cycle, pending a majority vote from member states.

Concurrently, Tesla is executing a dramatic industrial pivot. In its historic Fremont plant, the final Model S and Model X vehicles will roll off the line in Q2 2026. The freed-up space will be repurposed for the mass production of the Optimus humanoid robot, underscoring the company's evolution from a pure automaker into an AI and robotics enterprise. Tesla China President Wang Hao recently labeled the Shanghai production facilities a "golden key" for scaling this robot manufacturing, aiming to transfer years of automotive mass-production expertise directly to the Optimus program.

Wall Street is cautiously recalibrating its view amid these shifts. UBS analyst Joseph Spak upgraded the stock from "Sell" to "Neutral" on April 14, affirming a $352 price target. He cited a more balanced risk-reward profile following the stock's nearly 17% decline since the start of the year to around 310 euros. Cantor Fitzgerald's Andres Sheppard also maintained a Buy rating with a $510 target, calling the Dutch FSD approval significant and expecting further European clearances "soon." The stock currently trades about 26% below its December 2025 52-week high.

This ambitious transformation demands immense capital. Management has planned investments exceeding $20 billion for the current year, funding new factory capacity, data centers, and the planned robotaxi fleet. These expenditures unfold against a challenging automotive backdrop. Tesla's Q1 2026 delivery figure of 358,023 vehicles missed consensus estimates, continuing a trend of four consecutive quarters of underwhelming results. Production for the quarter was approximately 408,000 units, indicating a notable inventory build. UBS remains skeptical on the core auto business, forecasting stagnant deliveries of 1.6 million units for 2026 and growth to only around two million by 2030, well below the consensus of three million.

All eyes now turn to the detailed financial results, due after the US market close on Wednesday, April 22. Analysts expect earnings of $0.24 per share, a 60% increase year-over-year but from a low base. The automotive gross margin and supply chain issues will be key focuses. During the subsequent webcast, management faces the critical task of outlining a concrete timeline for scaling Optimus production and detailing the financing for its massive capital expenditure program, while also addressing the overhang of unsold vehicles.